Nomura Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-154,350
Closed -$2.48M – 1509
2024
Q2
$2.35M Sell
154,350
-275,150
-64% -$3.94M 0.01% 694
2024
Q1
$6.3M Hold
429,500
– – 0.02% 484
2023
Q4
$5.98M Hold
429,500
– – 0.02% 487
2023
Q3
$5.74M Buy
429,500
+200,000
+87% +$2.71M 0.03% 465
2023
Q2
$2.9M Hold
229,500
– – 0.01% 639
2023
Q1
$2.61M Hold
229,500
– – 0.01% 645
2022
Q4
$2.38M Hold
229,500
– – 0.01% 654
2022
Q3
$2.4M Sell
229,500
-119,500
-34% -$1.27M 0.02% 629
2022
Q2
$3.87M Hold
349,000
– – 0.02% 507
2022
Q1
$3.89M Hold
349,000
– – 0.02% 546
2021
Q4
$4.57M Hold
349,000
– – 0.02% 516
2021
Q3
$4.55M Hold
349,000
– – 0.03% 484
2021
Q2
$5.13M Sell
349,000
-77,000
-18% -$1.08M 0.03% 473
2021
Q1
$5.23M Buy
426,000
+76,000
+22% +$976K 0.03% 446
2020
Q4
$4.99M Sell
350,000
-10,000
-3% -$135K 0.03% 424
2020
Q3
$5.01M Buy
360,000
+78,500
+28% +$936K 0.04% 379
2020
Q2
$2.98M Buy
281,500
+158,000
+128% +$1.61M 0.03% 469
2020
Q1
$996K Hold
123,500
– – 0.01% 699
2019
Q4
$1M Buy
+123,500
New +$975K 0.01% 785
2014
Q2
– Sell
-34,705
Closed -$305K – 883
2014
Q1
$305K Buy
34,705
+14,705
+74% +$128K 0.01% 816
2013
Q4
$164K Sell
20,000
-21,500
-52% -$170K ﹤0.01% 864
2013
Q3
$314K Sell
41,500
-33,500
-45% -$244K 0.01% 802
2013
Q2
$567K Buy
+75,000
New +$548K 0.01% 702

Other funds holding RDY

Nomura Asset Management's RDY Position: Q3 2024 in Review

Nomura Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 154,350 shares — an estimated $2.48M sold.

Nomura Asset Management first reported a position in RDY in Q2 2013 and held it in 23 quarters. The position peaked at $6.3M in Q1 2024. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

  • Nomura Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
  • Nomura Asset Management sold 154,350 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $2.48M.
  • Nomura Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 23 quarters.
  • Nomura Asset Management's Dr. Reddy's Laboratories position peaked at $6.3M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Nomura Asset Management's 13F filing for Q3 2024, filed 15 Nov 2024.